ஷான் ஃபூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 27, 2021 By Alex Keown Singapore-based Esco Lifesciences closed a  $200 million oversubscribed Series A financing and crossover round that will enable the company that provides life sciences tools and services to expand its toehold in China and the United States.  Esco is a manufacturer of laboratory and biopharma equipment and IVF medical devices. The company has four different divisions, Scientific, Medical, Healthcare, and Aster, which offers “mission-critical equipment and advanced solutions” to laboratories, clinics, and bio-pharma production sites in over 100 countries.  The company employs more than 1,300 people across the globe. It has offices in more than 100 companies, including eight manufacturing and R&D hubs in the US, Europe, the UK, China, and Singapore. The financing round is the largest private fundraising round by an Asia-based life sciences tools company, Esco said in its announcement. 

United statesUnited kingdomShan fuKasim kutayEsco lifesciencesAmit kakarChina investment corporationNovo holdings asiaNovo holdingsVivo capitalIesco boardGreater chinaIngapore biopharma manufacturer raises 200 million series aஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஷான் ஃபூ